Surgical Treatment Outcomes of Spinal Metastases of Nasopharyngeal Carcinoma: The First Report of 30 Patients from a Single Center

References

• Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–2054. doi:10.1016/S0140-6736(05)66698-615950718
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• De Felice F, Musio D, Magnante AL, et al. Solitary rib metastasis of nasopharyngeal carcinoma. Chin J Cancer Res. 2014;26(2):219–221. doi:10.3978/j.issn.1000-9604.2014.03.0224826065
   PubMed Web of Science ®Google Scholar
• Micheau C, Rilke F, Pilotti S. Proposal for a new histopathological classification of the carcinomas of the nasopharynx. Tumori J. 1978;64(5):513–518. doi:10.1177/030089167806400509
   PubMed Web of Science ®Google Scholar
• Lin S, Pan J, Han L, et al. Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin. Radiother Oncol. 2014;110(3):385–389. doi:10.1016/j.radonc.2014.01.01124560755
   PubMed Web of Science ®Google Scholar
• Peng G, Wang T, Yang K-Y, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):286–293. doi:10.1016/j.radonc.2012.08.01322995588
   PubMed Web of Science ®Google Scholar
• Teo PML, Kwan WH, Lee WY, et al. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer. 1996;77(12):2423–2431. doi:10.1002/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N8640688
   PubMed Web of Science ®Google Scholar
• Hui EP, Leung SF, Au JSK, et al. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer. 2004;101(2):300–306. doi:10.1002/cncr.2035815241827
   PubMed Web of Science ®Google Scholar
• Cao C-N, Luo J-W, Gao L, et al. Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: an analysis of survival and treatment toxicities. Oral Oncol. 2015;51(2):190–194. doi:10.1016/j.oraloncology.2014.11.00925434585
   PubMed Web of Science ®Google Scholar
• Leung SF, Teo PM, Shiu WW, et al. Clinical features and management of distant metastases of nasopharyngeal carcinoma. J Otolaryngol. 1991;20(1):27–29.1709423
   PubMedGoogle Scholar
• Gacani W, Bal IS, Babu MA, et al. Distance metastases from nasopharyngeal carcinoma at Kenyatta Nairobi hospital, Kenya. East Afr Med J. 2001;78(12):678–681. doi:10.4314/eamj.v78i12.894012199453
   PubMedGoogle Scholar
• Bensouda Y, Kaikani W, Ahbeddou N, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(2):79–85. doi:10.1016/j.anorl.2010.10.00321177151
   PubMed Web of Science ®Google Scholar
• Zhao C-L, Qian G-Q, Chen X-Y, et al. Retrograde analysis of clinical characteristics of bone metastasis in 1031 cases of preliminarily diagnosed nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2014;15(8):3785–3788. doi:10.7314/apjcp.2014.15.8.378524870794
   PubMedGoogle Scholar
• Jin Y, An X, Cai YC, et al. Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma. J Cancer Res Clin Oncol. 2011;137(10):1545–1551. doi:10.1007/s00432-011-1027-821842218
   PubMed Web of Science ®Google Scholar
• Shen L, Dong J, Li S, et al. M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma. Oncologist. 2015;20(3):291–298. doi:10.1634/theoncologist.2014-020625660157
   PubMed Web of Science ®Google Scholar
• Lu T, Guo Q, Cui X, et al. Prognostic evaluation of nasopharyngeal carcinoma with bone-only metastasis after therapy. Yonsei Med J. 2016;57(4):840–845. doi:10.3349/ymj.2016.57.4.84027189275
   PubMed Web of Science ®Google Scholar
• Kumar N, Tan JJH, Zaw AS, et al. Evaluation of scoring systems and prognostic factors in patients with spinal metastases from nasopharyngeal carcinoma. Spine J. 2014;14(12):2946–2953. doi:10.1016/j.spinee.2014.06.00124912121
   PubMed Web of Science ®Google Scholar
• Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia. 1969;7(3):179–192. doi:10.1038/sc.1969.305360915
   PubMedGoogle Scholar
• Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine. 2001;26(3):298–306. doi:10.1097/00007632-200102010-0001611224867
   PubMed Web of Science ®Google Scholar
• Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;204:9–24.
   Google Scholar
• Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine. Terminology and surgical staging. Spine. 1997;22(9):1036–1044. doi:10.1097/00007632-199705010-000209152458
   PubMed Web of Science ®Google Scholar
• Liu F-Y, Chang JT, Wang H-M, et al. [18 F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2006;24(4):599–604. doi:10.1200/JCO.2005.03.876016446332
   PubMed Web of Science ®Google Scholar
• Tiruchelvarayan R, Lee KA, Ng I. Surgery for atlanto-axial (C1–2) involvement or instability in nasopharyngeal carcinoma patients. Singapore Med J. 2012;53(6):416–421.22711043
   PubMed Web of Science ®Google Scholar
• Sham JST, Cheung YK, Chan FL, et al. Nasopharyngeal carcinoma: pattern of skeletal metastases. Br J Radiol. 1990;63(747):202–205. doi:10.1259/0007-1285-63-747-2022334832
   PubMed Web of Science ®Google Scholar
• Cao X, Han Y, He L, et al. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment? Oral Oncol. 2011;47(8):747–752. doi:10.1016/j.oraloncology.2011.05.01021665523
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen H, Hu B, et al. Prognostic significance of Ki67 expression and the derived neutrophil–lymphocyte ratio in nasopharyngeal carcinoma. Cancer Manag Res. 2018;10:1919–1926. doi:10.2147/CMAR.S16762630013398
   PubMed Web of Science ®Google Scholar
• Mott FE, Ferrarotto R, Nguyen T, et al. Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy. Oral Oncol. 2018;81:75–80. doi:10.1016/j.oraloncology.2018.04.02029884417
   PubMed Web of Science ®Google Scholar
• Rief H, Muley T, Bruckner T, et al. Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients. Strahlenther Onkol. 2014;190(1):59–63. doi:10.1007/s00066-013-0431-124052009
   PubMed Web of Science ®Google Scholar
• Toh C-K, Heng D, Ong Y-K, et al. Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma. Br J Cancer. 2005;92(8):1382–1387. doi:10.1038/sj.bjc.660252515812546
   PubMed Web of Science ®Google Scholar
• Schwartz MK. Lactic dehydrogenase: an old enzyme reborn as a cancer marker? Am J Clin Pathol. 1991;96(4):441–443. doi:10.1093/ajcp/96.4.4411892120
   PubMed Web of Science ®Google Scholar
• Turen S, Ozyar E, Altundag K, et al. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Cancer Invest. 2007;25(5):315–321. doi:10.1080/0735790070120910317661206
   PubMed Web of Science ®Google Scholar
• Jin Y, Ye X, Shao L, et al. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy. Eur J Cancer. 2013;49(7):1619–1626. doi:10.1016/j.ejca.2012.11.03223266049
   PubMed Web of Science ®Google Scholar
• Jin Y, Yuan MQ, Chen JQ, et al. Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma. Clinics. 2015;70(4):264–272. doi:10.6061/clinics/2015(04)0826017793
   PubMed Web of Science ®Google Scholar
• Ahn HK, Jung M, Ha S-Y, et al. Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer. Tumour Biol. 2014;35(6):5735–5740. doi:10.1007/s13277-014-1760-024737581
   PubMedGoogle Scholar
• Luporsi E, Andre F, Spyratos F, et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat. 2012;132(3):895–915. doi:10.1007/s10549-011-1837-z22048814
   PubMed Web of Science ®Google Scholar
• Yang M, Xu W, Liu T, et al. Development and validation of a novel survival prediction model in patients with spinal metastasis from non-small cell lung cancer. Spine. 2019;44(4):246–257. doi:10.1097/BRS.000000000000281630059487
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang Z, Zhong N, et al. Outcomes and prognostic factors for surgically treated patients with breast cancer spine metastases. J Bone Oncol. 2018;12:38–43. doi:10.1016/j.jbo.2018.03.00330050751
   PubMed Web of Science ®Google Scholar
• Huang W, Wei H, Cai W, et al. Total en bloc spondylectomy for solitary metastatic tumors of the fourth lumbar spine in a posterior-only approach. World Neurosurg. 2018;120:e8–e16. doi:10.1016/j.wneu.2018.06.25129990608
   PubMed Web of Science ®Google Scholar
• Kawahara N, Tomita K, Murakami H, et al. Total en bloc spondylectomy for spinal tumors: surgical techniques and related basic background. Orthop Clin North Am. 2009;40(1):47–63. doi:10.1016/j.ocl.2008.09.00419064055
   PubMed Web of Science ®Google Scholar